@article{devos_d_rivastigmine_2014,
title = {Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial},
volume = {85},
issn = {0022-3050},
url = {http://www.ncbi.nlm.nih.gov/pubmed/24218528},
DOI = {10.1136/jnnp-2013-306439},
Language = {English},
Journal = {J. Neurol. Neurosurg. Psychiatry},
author = {{Devos D} and {Moreau C} and {Maltete D} and {Lefaucheur R} and {Kreisler A} and {Eusebio A} and {Defer G} and {Ouk T} and {Azulay JP} and {Krystkowiak P} and {Witjas T} and {Delliaux M} and {Destee A} and {Duhamel A} and {Bordet R} and {Defebvre L} and {Dujardin K}},
year = {2014},
keywords = {Activities of Daily Living, Adult, Aged, Apathy*, Cholinesterase Inhibitors/therapeutic use*, Dementia/diagnosis, Depression/diagnosis, Double-Blind Method, Female, Humans, Male, Middle Aged, Neuroprotective Agents/therapeutic use*, Parkinson Disease/drug therapy*, Parkinson Disease/psychology*, Phenylcarbamates/therapeutic use*, Prospective Studies, Rivastigmine, Severity of Illness Index},
pages = {668-674}
}

{"_id":"m4dJhh2Xy4ANmotxC","bibbaseid":"devosd-moreauc-malteted-lefaucheurr-kreislera-eusebioa-deferg-oukt-etal-rivastigmineinapatheticbutdementiaanddepressionfreepatientswithparkinsonsdiseaseadoubleblindplacebocontrolledrandomisedclinicaltrial-2014","authorIDs":[],"author_short":["Devos D","Moreau C","Maltete D","Lefaucheur R","Kreisler A","Eusebio A","Defer G","Ouk T","Azulay JP","Krystkowiak P","Witjas T","Delliaux M","Destee A","Duhamel A","Bordet R","Defebvre L","Dujardin K"],"bibdata":{"bibtype":"article","type":"article","title":"Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial","volume":"85","issn":"0022-3050","url":"http://www.ncbi.nlm.nih.gov/pubmed/24218528","doi":"10.1136/jnnp-2013-306439","language":"English","journal":"J. Neurol. Neurosurg. Psychiatry","author":[{"firstnames":[],"propositions":[],"lastnames":["Devos D"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Moreau C"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Maltete D"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Lefaucheur R"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Kreisler A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Eusebio A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Defer G"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Ouk T"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Azulay JP"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Krystkowiak P"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Witjas T"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Delliaux M"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Destee A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Duhamel A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Bordet R"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Defebvre L"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Dujardin K"],"suffixes":[]}],"year":"2014","keywords":"Activities of Daily Living, Adult, Aged, Apathy*, Cholinesterase Inhibitors/therapeutic use*, Dementia/diagnosis, Depression/diagnosis, Double-Blind Method, Female, Humans, Male, Middle Aged, Neuroprotective Agents/therapeutic use*, Parkinson Disease/drug therapy*, Parkinson Disease/psychology*, Phenylcarbamates/therapeutic use*, Prospective Studies, Rivastigmine, Severity of Illness Index","pages":"668-674","bibtex":"@article{devos_d_rivastigmine_2014,\r\ntitle = {Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial},\r\nvolume = {85},\r\nissn = {0022-3050},\r\nurl = {http://www.ncbi.nlm.nih.gov/pubmed/24218528},\r\nDOI = {10.1136/jnnp-2013-306439},\r\nLanguage = {English},\r\nJournal = {J. Neurol. Neurosurg. Psychiatry},\r\nauthor = {{Devos D} and {Moreau C} and {Maltete D} and {Lefaucheur R} and {Kreisler A} and {Eusebio A} and {Defer G} and {Ouk T} and {Azulay JP} and {Krystkowiak P} and {Witjas T} and {Delliaux M} and {Destee A} and {Duhamel A} and {Bordet R} and {Defebvre L} and {Dujardin K}},\r\nyear = {2014},\r\nkeywords = {Activities of Daily Living, Adult, Aged, Apathy*, Cholinesterase Inhibitors/therapeutic use*, Dementia/diagnosis, Depression/diagnosis, Double-Blind Method, Female, Humans, Male, Middle Aged, Neuroprotective Agents/therapeutic use*, Parkinson Disease/drug therapy*, Parkinson Disease/psychology*, Phenylcarbamates/therapeutic use*, Prospective Studies, Rivastigmine, Severity of Illness Index},\r\npages = {668-674}\r\n}\r\n\r\n","author_short":["Devos D","Moreau C","Maltete D","Lefaucheur R","Kreisler A","Eusebio A","Defer G","Ouk T","Azulay JP","Krystkowiak P","Witjas T","Delliaux M","Destee A","Duhamel A","Bordet R","Defebvre L","Dujardin K"],"key":"devos_d_rivastigmine_2014","id":"devos_d_rivastigmine_2014","bibbaseid":"devosd-moreauc-malteted-lefaucheurr-kreislera-eusebioa-deferg-oukt-etal-rivastigmineinapatheticbutdementiaanddepressionfreepatientswithparkinsonsdiseaseadoubleblindplacebocontrolledrandomisedclinicaltrial-2014","role":"author","urls":{"Paper":"http://www.ncbi.nlm.nih.gov/pubmed/24218528"},"keyword":["Activities of Daily Living","Adult","Aged","Apathy*","Cholinesterase Inhibitors/therapeutic use*","Dementia/diagnosis","Depression/diagnosis","Double-Blind Method","Female","Humans","Male","Middle Aged","Neuroprotective Agents/therapeutic use*","Parkinson Disease/drug therapy*","Parkinson Disease/psychology*","Phenylcarbamates/therapeutic use*","Prospective Studies","Rivastigmine","Severity of Illness Index"],"downloads":0},"bibtype":"article","biburl":"https://pro.univ-lille.fr/fileadmin/user_upload/pages_pros/patrick_devos/duhamel.bib","creationDate":"2019-06-21T09:30:55.057Z","downloads":0,"keywords":["activities of daily living","adult","aged","apathy*","cholinesterase inhibitors/therapeutic use*","dementia/diagnosis","depression/diagnosis","double-blind method","female","humans","male","middle aged","neuroprotective agents/therapeutic use*","parkinson disease/drug therapy*","parkinson disease/psychology*","phenylcarbamates/therapeutic use*","prospective studies","rivastigmine","severity of illness index"],"search_terms":["rivastigmine","apathetic","dementia","depression","free","patients","parkinson","disease","double","blind","placebo","controlled","randomised","clinical","trial","devos d","moreau c","maltete d","lefaucheur r","kreisler a","eusebio a","defer g","ouk t","azulay jp","krystkowiak p","witjas t","delliaux m","destee a","duhamel a","bordet r","defebvre l","dujardin k"],"title":"Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial","year":2014,"dataSources":["Tt6zYqvN5kE3wbwiR"]}